Prolonged Survival in a Non-Small Cell Lung Cancer with Brain Metastasis Treated with a Brain Mass Evacuation and Gefi tinib
Main Authors: | Hardianti, Mardiah Suci, Kurnianda, Johan |
---|---|
Format: | Article info application/pdf eJournal |
Bahasa: | eng |
Terbitan: |
Faculty of Medicine Universitas Gadjah Mada
, 2017
|
Subjects: | |
Online Access: |
http://journal.ugm.ac.id/jain/article/view/22393 http://journal.ugm.ac.id/jain/article/view/22393/14942 |
Daftar Isi:
- The incidence of brain metastasis (BM) is reported to be increase about 20-40% over the last few years in patients with non-small-cell lung cancer (NSCLC).1 The use of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) in NSCLC patients with BM, especially those harboring EGFR mutations have been reported.